Laboratory Animal Services STANDARD OPERATING PROCEDURES AND POLICIES ANAESTHESIA and PAIN MANAGEMENT - RODENTS (Last updated 29 April 2005) SECTION 1: GENERAL COMMENTS The need for pain management It is a legal requirement that persons using animals for research “must assume that animals experience pain in a manner similar to humans”. Furthermore, there can be no doubt that the physiological effects of pain are potentially diverse and can have a major impact on research data. Appropriate attention to pain management is therefore one of the most important responsibilities of those involved in the use of animals for scientific purposes. Procedural skills It is essential that the persons performing any procedure requiring anaesthesia are competent in that procedure. This is required by legislation and is a condition that must be satisfied when applying to the Animal Ethics Committee for approval. Apart from the obvious animal welfare implications, poor technique will prolong anaesthetic recovery and increase the chance of side-effects that can adversely affect the quality of experimental data. Preparation for anaesthesia Unlike humans (and certain other monogastrics such as dogs and cats), rodents should not be starved prior to general anaesthesia. It is important to have an accurate idea of the animal’s body weight so that the correct dose of drug is administered. Different strains of rodent vary considerably in the way they handle anaesthesia. Therefore, when using an anaesthetic drug (or combination of drugs) for the first time, it is always advisable to anaesthetise a single animal first rather than a group. This enables one to observe the effects of the anaesthetic protocol on that particular strain of rodent. When administering anaesthetic drugs, it is best to administer the drug to effect rather than give the full dose all at once. This helps avoid over-dosing. The use of pre-anaesthetic medication (‘pre-med’) is not generally practiced with rodents. Frequent handling and conditioning can be valuable in reducing the amount of restraint and stress for the animal. What to avoid 1) Hypothermia Hypothermia (a potentially fatal reduction in body temperature) develops extremely rapidly in rodents and is probably the commonest cause of anaesthetic death. In its mildest form, it will lead to a substantial increase in the time taken to recover from an anaesthetic; this in turn can induce a wide variety of metabolic alterations. When more severe, animals become more susceptible to anaesthetic overdose and shock. Hypothermia can be minimised or prevented by the following procedures: 1) Use of a thermostatically-controlled heating pad. 2) Use of a heat lamp. This is less controllable than a heat pad and can lead to burns or a dangerous increase in body temperature (hyperthermia). Careful monitoring of either the animal’s temperature or the operative field is essential. 3) Wrapping the animal’s torso in plastic bubble-wrap or cotton wool. This is suitable for short procedures but should not be relied on too heavily and care should be taken to ensure that breathing movements can still be observed. The tail should be included in the wrapping since this can be an important route of heat loss. Note that procedures such as swabbing with cold (i.e. room temperature) disinfectants, injection of cold solutions, clipping of hair and haemorrhage will all contribute to the development of hypothermia. 2) Anaesthetic overdose 2 This most commonly occurs when the animal’s body weight has been overestimated. Another important cause, however, is metabolic differences between individuals or between strains of animal – such differences can cause marked variation in susceptibility to anaesthetic drugs. 3) Eye damage General anaesthesia can lead to loss of blink reflex or drying of the surface of the eye. It is important to protect the surface of the eye from drying or injury either through covering the eyes or applying an ointment. 4) Hepatic enzyme induction Repeated or prolonged administration of anaesthetic (or other) drugs can lead to alterations in the way the liver metabolises many substances as well as the drugs responsible. This must be kept in mind when planning experiments involving liver function or the systemic administration of substances. Monitoring anaesthesia Anaesthesia is a dynamic state and the depth of anaesthesia can be altered by many factors. These include intensity of stimulus, amount of body fat, genetic factors, physiological state, duration of anaesthesia and of course the drugs used. It is therefore important that anaesthesia be monitored throughout the procedure. Many devices used for monitoring anaesthesia in larger animals are not sufficiently sensitive for use in rodents. The ability to make a clinical assessment of anaesthesia by direct observation is therefore very important. Experience and familiarity with a particular anaesthetic regime are also extremely valuable when ensuring that anaesthesia is maintained at an appropriate depth. Specific parameters that can be used to monitor anaesthetic depth in rodents include: Pinching the skin between the toes or the tail tip: a movement response suggests anaesthesia might be too light; Changes in the rate or depth of respiration: slow and shallow suggests anaesthesia might be too deep, vice versa too light; Colour of tissues, skin or mucous membranes: should be pink, not maroon or bluish. Body temperature. This requires devices such as a rectal probe or infra-red thermometer. Post-operative care 1) Anaesthetic recovery Animals should be placed in a cage lined with a cloth, towel or shredded paper. Dusty materials should not be used because particles might stick to the eyes. The animal must be kept warm and the environment should be quiet, free of obtrusive human activity and preferably dimly lit (except when examining the animal). 2) Respiratory depression If there appears to be significant respiratory depression (breathing is excessively slow or shallow), recovery from some anaesthetic drugs can be assisted with the use of specific reversing agents (see table). A possible alternative is the use of doxapram (a respiratory stimulant) at a dose rate of 5 – 10 mg/kg IV, IM or IP every 15 minutes. Supplying oxygen into the cage at a low slow-rate can also be beneficial. 3) Fluid replacement Excessive loss of fluids through bleeding or evaporation (when a body cavity is opened) will rapidly lead to complications such as circulatory shock. This in turn will affect the function of many organs in a manner that could have an impact on research data. Note that in a small animal such as a mouse, a few drops of blood represents a substantial proportion of the animal’s blood volume and can be fatal. Fluid loss should therefore be minimized and lost fluids replaced. If substantial fluid loss is anticipated, calculation of fluid replacement requirements can be estimated by weighing the animal before and after the procedure. Lost fluids can be replaced using solutions such as 0.9% saline or lactated Ringer’s solution preferably warmed to 37C and administered SC or IP. Note also that animals recovering from surgery might not be able to eat or drink for some time. In such cases, they should be provided with moist foods (nutrient agar, jelly or crushed rodent pellets mixed with water) 3 presented in a dish or other manner that does not require the animal to reach up high. Typically, an animal requires approximately 50 ml of fluid every per kg body weight every 24 hours. Detection of pain It should be assumed that animals are affected by pain to a similar extent as humans even though they might perceive it differently. Although application of commonsense is one of the most valuable skills in the detection of pain, animals undergoing procedures should be observed for a range of signs including: Altered behaviour (more submissive or more aggressive); Abnormal posture or gait/avoiding the use of a limb; Decline in body weight; Dull or roughened coat; Laboured or rapid respiration; Dehydration (skin is not easily pliable, eyes appear sunken). Surgical wounds should also be inspected regularly for signs of inflammation (swelling, discharge etc). Record keeping It is a legal requirement that animals used in research are appropriately monitored and that this is properly recorded. This is particularly important in cases where animals are undergoing invasive procedures such as surgery. Failure to meet this obligation may result in withdrawal of animal ethics approval. In cases where animals are undergoing potentially painful procedures, the Animal Ethics Committee will usually require that an appropriate and clear record be kept for each animal. These records must be readily available in the animal room for inspection by members of the animal house staff and the Animal Ethics Committee. Records for animals no longer in the animal house should be filed in the researcher’s office. A template record and other information is available from the Laboratory Animal Services Director or the Ethics Office. Security and occupational safety All anaesthetic drugs hold considerable potential for serious occupational injury and abuse. It is essential that they are only supplied to and handled by persons named on the Animal Ethics approval. It is a condition of supply that they be kept in a secure location that is not accessible to persons . Obtaining anaesthetic drugs Researchers may be supplied with prescription-controlled drugs for anaesthesia of animals for approved research purposes. These can usually be ordered through LAS upon application to the Director. You may be required to provide a copy of the AEC letter approving your project as well as a full copy of the AEC protocol in which the proposed use of the drug is described. You must also provide an account code to which the cost of the drug(s) can be charged. SECTION 2: DRUGS AND DOSE RATES Choice of drugs There are many drugs available for anaesthesia of rodents. Those listed in the table below are suggested as a starting point only. They have been chosen because they are relatively free of undesirable side effects, are commonly used and are simple to administer. Alternative drugs might be more suitable for certain applications. Note that the membership of the University of Sydney’s Animal Ethics Committee includes a veterinary anaesthetist with extensive experience in the anaesthesia of laboratory animal species. Long-term (greater than 1 hour) anaesthesia. The drugs listed in the table below are best used for procedures of short to medium duration. Longer term procedures will usually require a different approach. 4 For many longer term procedures, an inhalation anaesthetic delivered via a well made face mask connected to an anaesthetic machine with suitable vapouriser is the most reliable. Note that any method of delivering anaesthetic gases must ensure adequate removal (‘scavenging’) of waste gases to avoid possible short-term and long-term health effects on the operator. Long-term anaesthesia can also be provided using injectable agents administered IM or IP on a top-up basis although this results in variable anaesthetic depth. A more precise alternative among the injectable procedures is continuous intravenous administration. This usually requires an infusion pump. Drugs suited to intravenous infusion in rodents include alphaxalone and propofol. MICE Type of anaesthesia Light sedation Light sedation Light to deep sedation Sedation Sedation Deep sedation or restraint for noninvasive procedures Restraint for minimally invasive procedures Duration Drug Dose (mg/kg) Comment 20 – 30 min 20 – 30 min 20 – 30 min Acetylpromazine Xylazine Meditomidine 2 – 5 mg/kg IP or SC 5 mg/kg IP 30 – 100 g/kg SC 20 – 30 min 45 min Diazepam Alphaxalone Ketamine 5 mg/kg IM or IP 100 mg/kg IP 150 mg/kg IP 20 – 40 min (sleep time > 2 hr) Pentobarbitone IP Light surgical anaesthesia 20 – 30 min. Sleep time 1 – 2 hrs. Ketamine and acetylpromazine Ket 100 mg/kg Ace 5 mg/kg IP Surgical anaesthesia 20 – 30 min. Sleep time 1 – 2 hrs. Ketamine (100mg/ml) and xylazine (20mg/ml) Ket 75 mg/kg Xyl 10 mg/kg IP Does not provide analgesia Provides mild analgesia Provides mild analgesia. Reversed with atipamezole (1 mg/kg IP) Does not provide analgesia Poor analgesia; can be inconsistent. Produces increase in muscle tone and slight increase in blood pressure. Must not be used for invasive procedures unless combined with analgesic drugs (see below). Provides poor analgesia and can cause significant cardiovascular and respiratory depression. Commercial production of anaesthetic grade pentobarbitone is now very limited. Other, shorter-acting barbiturates are available but references usually cite these for IV use. Note that ketamine is now a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. Xylazine can be partially reversed with atipamezole. Note that ketamine is now a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. 0.3 ml undiluted Dilute ketamine (100mg/ml) 1 in 5 to make 20 mg/ml; administer 0.1 ml per mouse. OR 2.5mg/33g mouse=0.025ml ket 0.33mg/33g mouse=0.017ml xyl Surgcial 20 – 30 min. Ketamine and Ket 75 mg/kg For multiple mice: using a 1 ml syringe, administer 0.04ml/mouse of a solution of ket:xyl in ratio of 0.5mlket+0.34mlxyl Dilute ketamine Medetomidine can be reversed with atipamezole. 6 anaesthesia Sleep time 1 – 2 hrs. medetomidine Med 1 mg/kg IP Surgical anaesthesia 60 – 70 min if not reversed. Sleep time 4 – 6 hrs if not reversed. Fentanyl and medetomidine Not for use in mice? Surgical anaesthesia 15 -45 min (sleep time 1 -2 hr) 30 – 60 sec Tribromoethanol (‘Avertin’) 250 mg/kg IP Isoflurane Surgical anaesthesia Determined by duration of administration Isoflurane Surgical anaesthesia Determined by duration of administration Halothane OR enflurane Best done by running anaesthetic gas into a transparent container using an anaesthetic machine. Simple but crude alternative is to place cotton wool with a few drops of isoflurane in large jar or transparent chamber then place mesh over cotton wool. Animal is placed on mesh and removed as soon as consciousness is lost. Delivered by anaesthetic machine with oxygen. Must use vapouriser calibrated to isoflurane. Usually administered via face mask which must be well-fitting. Delivered by anaesthetic machine with oxygen. Must Very brief anaesthesia or induction (100mg/ml) 1 in 5 to make 20 mg/ml; dilute medetomidine (1mg/ml) 1 in 3 to make 0.3 mg/ml. Mix with equal part of diluted ketamine. Administer 0.2 ml of mixture per 30 g mouse. Note that ketamine is now a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. Medetomidine is reversed with atipamezole (1 mg/kg IP). Fentanyl can be reversed by opioid antagonists. Note that fentanyl is a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. Contentious because can cause irritation of the peritoneum. Must be prepared fresh and stored correctly. Only suitable for very brief, minimally invasive procedures or for initial induction of anaesthesia with subsequent maintenance by other means. If not using anaesthetic machine, must avoid direct contact between isoflurane liquid and animal because drug is very irritant to mucous membranes. Need to take care to avoid occupational exposure. Causes negligible induction of hepatic enzymes therefore is sometimes recommended over other inhalation agents. Rapid induction and recovery. Widely used in the past; now being superceded by isoflurane. Note halothane is associated with possible long term occupational health risks. 7 Surgical anaesthesia Determined by duration of administration Methoxyflurane Post-operative pain relief 24 hr Carprofen, ketoprofen or meloxicam Post-operative pain relief 12 hr Buprenorphine (‘Temgesic’) use vapouriser calibrated to halothane or enflurane. Usually administered via face mask which must be well-fitting. Delivered by anaesthetic machine with oxygen. Must use vapouriser calibrated to methoxyflurane. Usually administered via face mask which must be well-fitting. 3 – 5 mg/kg SC, IM or PO 0.05 mg/kg SC or IM. Can also be offered in jelly form for postoperative administration. Induction of anaesthesia is slow and therefore safer than other inhalation agents. Good for anaesthesia of neonates. All these are non-steroidal anti-inflammatory drugs (NSAIDs) that act on peripheral pain mechanisms; also have anti-inflammatory and anti-pyretic (fever-reducing) effects. May be used in association with opioids or as an alternative if opioids would interfere with procedure. Oral administration can be achieved by supplying drug in flavoured jelly (make up jelly double strength and add drug so that cubes of jelly contain one 24 hour dose); must be only one animal per cage and animals should be accustomed to jelly be feeding drug-free jelly 2 to 3 days beforehand. Opioid agonist i.e. acts on central pain receptors. Note that the undesirable side-effects of opioids observed in humans tend to be less marked in animals. Buprenorphine may be used with or as an alternative to NSAIDs. Can be delivered in jelly (see above). Exceeding the recommended dose can lead to a reduction in analgesic effect. Note that buprenorphine is a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. RATS Type of anaesthesia Duration Drug Dose (mg/kg) Comment 8 Light sedation Light to heavy sedation Light to heavy sedation Light sedation Deep sedation or restraint for noninvasive procedures 20 – 30 min 20 – 30 min Acetylpromazine Xylazine 2 – 5 mg/kg IM, IP or SC 1 - 5 mg/kg IM or IP Does not provide analgesia Provides mild analgesia 20 – 30 min Meditomidine 30 – 100 ug/kg IM, IP or SC 20 – 30 min 20 – 30 min Diazepam Ketamine 2.5 – 5.0 mg/kg IM or IP 75 mg/kg IM or IP Restraint for minimally invasive procedures 20 – 40 min (sleep time > 2 hr) Pentobarbitone IP Light surgical anaesthesia 20 – 30 min. 2 – 4 hrs sleep time. Ketamine and acetylpromazine Ket 75 mg/kg Ace 2.5 mg/kg IP Surgical anaesthesia 20 – 30 min. 2 – 4 hrs sleep time. Ketamine and xylazine Ket 75 mg/kg Xyl 10 mg/kg IP Surgical anaesthesia 20 – 30 min. 2 – 4 hrs sleep time if not reversed. Ketamine and medetomidine Ket 75 mg/kg Med 0.5 mg/kg IP Does not provide analgesia. Reversed with atipamezole (1 mg/kg IP) Does not provide analgesia Produces increase in muscle tone and slight increase in blood pressure. Must not be used for invasive procedures unless combined with analgesic drugs (see below). Note that ketamine is now a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. Provides poor analgesia and can cause significant cardiovascular and respiratory depression. Commercial production of anaesthetic grade pentobarbitone is now very limited. Other, shorter-acting barbiturates are available but references usually cite these for IV use. Note that ketamine is now a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. Xylazine can be partially reversed with atipamezole. Note that ketamine is now a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. Medetomidine can be reversed with atipamezole. Note that ketamine is now a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. Surgical anaesthesia 60 – 70 min if not reversed. 4 – 6 hrs if not reversed. Fentanyl and medetomidine Fen 0.3 mg/kg Med 0.3 mg/kg IP Administer 0.25 ml ketamine (100mg/ml) mixed with 0.15 ml medetomidine (1mg/ml) in same syringe. Medetomidine is reversed with atipamezole (1 mg/kg IP). Fentanyl can be reversed by opioid antagonists. Note that fentanyl is a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. 9 Surgical anaesthesia 15 -45 min (sleep time 1 -2 hr) Tribromoethanol (‘Avertin’) 240 mg/kg IP Contentious because can cause irritation to peritoneum. Must be prepared fresh and stored correctly. Very brief anaesthesia or induction 30 – 60 sec Isoflurane Only suitable for very brief, minimally invasive procedures or for initial induction of anaesthesia with subsequent maintenance by other means. If not using anaesthetic machine, must avoid direct contact between isoflurane liquid and animal because drug is very irritant to mucous membranes. Need to take care to avoid occupational exposure. Surgical anaesthesia Determined by duration of administration Isoflurane Surgical anaesthesia Determined by duration of administration Halothane OR enflurane Surgical anaesthesia Determined by duration of administration Methoxyflurane Post-operative pain relief 24 hr Carprofen, ketoprofen or meloxicam Best done by running anaesthetic gas into a transparent container using an anaesthetic machine. Simple but crude alternative is to place cotton wool with a few drops of isoflurane in large jar or transparent chamber then place mesh over cotton wool. Animal is placed on grid and removed as soon as consciousness is lost. Delivered by anaesthetic machine with oxygen; must have vapouriser calibrated to isoflurane. Usually administered via face mask which must be well-fitting. Delivered by anaesthetic machine with oxygen. Must use vapouriser calibrated to halothane or enflurane. Usually administered via face mask which must be well-fitting. Delivered by anaesthetic machine with oxygen. Must use vapouriser calibrated to methoxyflurane. Usually administered via face mask which must be well-fitting. 3 – 5 mg/kg SC, IM or PO Causes negligible induction of hepatic enzymes therefore is sometimes recommended over other inhalation agents. Rapid induction and recovery. Widely used in the past; now being superceded by isoflurane. Note halothane is associated with possible long term occupational health risks. Induction of anaesthesia is slow and therefore safer than other inhalation agents. Very good for anaesthesia of neonates. All these are non-steroidal antiinflammatory drugs (NSAIDs) that act on peripheral pain mechanisms; also have anti-inflammatory and anti-pyretic (feverreducing) effects. May be used in association with opioids or as an alternative if opioids would interfere with procedure. Oral administration can be achieved by supplying drug in flavoured jelly (make up jelly double strength and add drug so that cubes of jelly contain 10 Post-operative pain relief 12 hr Buprenorphine Long term, nonrecovery Several hours Urethane 0.05 – 0.05 mg/kg SC or IM. Can also be offered in jelly form for post-operative administration. one 24 hour dose); must be only one animal per cage and animals should be accustomed to jelly be feeding drug-free jelly 2 to 3 days beforehand. Opioid agonist i.e. acts on central pain receptors. Note that the undesirable side-effects of opioids observed in humans tend to be less marked in animals. Buprenorphine may be used with or as an alternative to NSAIDs. Can be delivered in jelly (see above). Exceeding the maximum dose can lead to a reduction in the analgesic effect. Note that buprenorphine is a restricted drug and requires Department of Health approval. Contact Laboratory Animal Services for further information. Note occupational health (carcinogenesis) risk.